IPCA Laboratories trades in green on the BSE

30 Aug 2013 Evaluate

IPCA Laboratories is currently trading at Rs. 621.00, up by 1.50 points or 0.24% from its previous closing of Rs. 619.50 on the BSE.

The scrip opened at Rs. 622.00 and has touched a high and low of Rs. 622.50 and Rs. 618.00 respectively. So far 2057 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 708.00 on 11-Jul-2013 and a 52 week low of Rs. 401.10 on 08-Nov-2012.

Last one week high and low of the scrip stood at Rs. 641.95 and Rs. 610.00 respectively. The current market cap of the company is Rs. 7836.96 crore.

The promoters holding in the company stood at 45.89% while Institutions and Non-Institutions held 36.46% and 17.65% respectively.

Credit rating agency, CRISIL has reaffirmed AA rating to IPCA Laboratories’ long term bank facilities worth Rs 1182.50 crore. The company has received the rating reaffirmation on the back of its well-diversified business risk profile (across therapeutic segments and geographies), established position in the formulations segment both, in domestic and international market, and integrated operations.

IPCA is one of India’s largest suppliers of bulk drugs, such as atenolol (anti-hypertensive), chloroquine and artemisinin derivatives (anti-malarial), furosemide (diuretic), and pyrantel salts (anthelmintic).

Ipca Laboratories Share Price

1590.55 17.35 (1.10%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.